Literature DB >> 27583211

Distant metastasis from oral cancer: A review and molecular biologic aspects.

Soussan Irani1.   

Abstract

Oral squamous cell carcinoma (OSCC) has been estimated to be the sixth most common cancer worldwide. The distant metastasis plays a critical role in the management and prognosis in oral cancer patients. Regarding the distant metastasis from the oral cancer, the hypopharynx is the most common primary site, followed by the base of tongue and anterior tongue. The present review article analyzes the characteristics of the distant metastases from the oral cavity from 1937 to 2015.

Entities:  

Keywords:  Incidence; metastasis; molecular biology; oral cancer

Year:  2016        PMID: 27583211      PMCID: PMC4981925          DOI: 10.4103/2231-0762.186805

Source DB:  PubMed          Journal:  J Int Soc Prev Community Dent        ISSN: 2231-0762


INTRODUCTION

Oral squamous cell carcinoma (OSCC) has been estimated to be the sixth most common cancer worldwide.[1] The distant metastasis plays a critical role in the management and prognosis of oral cancer patients.[2] Regarding the distant metastasis from the oral cancer, the hypopharynx is the most common primary site (60%), followed by the base of tongue (53%) and anterior tongue (50%).[3] The present article reviews the characteristics of distant metastases from the oral cavity to analyze all available information in the English language literature from 1937 to 2015. Metastases from the major salivary glands are not included in this review. In addition, metastasis to the cervical lymph nodes was not included.

BIOLOGY OF METASTASIS

Metastasis means the spread of the disease from one organ to another not directly connected to it. Cancer cells enter the vascular or lymphatic channels.[4] Metastasis starts from detaching the cancer cells from the primary site, spreading in the tissue, moving away through the extracellular matrix, invading blood vessels, and settling in the microvasculature, and finally, extravasating through the vessel wall and proliferating in the recipient tissue.[5] Epithelial-mesenchymal transition (EMT) promotes metastasis due to loss of cell–cell adhesion and secretion of matrix metalloproteinases (MMPs) to degrade the extracellular matrix (ECM).[678] Anoikis, a specific form of apoptosis, occurs after detachment of the cells from the ECM[9] and facilitates metastasis.[10] Angiogenesis is another step for cancer metastasis as tumor cells should be transported via blood and/or lymph vessels.[11] Overexpression of vascular endothelial growth factors (VEGFs) has been reported in the cancers.[12] Tumor cells lining blood vessels “mosaic vessels” or “vasculogenic mimicry” may be another way for spreading cancer cells.[13] After surviving the immune system, the tumor cells extravasate into the organ parenchyma to establish a micrometastasis.[14] There are a few theories about the mechanism of metastasis. First, the “organ selection” theory suggesting the growth factors in the metastatic site may determine the establishment of successful metastasis. The second theory “adhesion theory” proposes that tissue specific adhesion molecules, expressing on endothelial cells of target organs, set up a pre-metastatic niche by anchoring migrating cancer cells to develop a metastatic tumor. Another is the “chemoattraction theory” that suggests that cancer cells express chemokine receptors.[15] Another theory proposes that the site and histopathological type of the primary cancer determine the organ distribution patterns, which first was reported by Paget in 1889, who proposed the concept of “seed” for metastatic tumor cells and of “soil” for the secondary site.[16] A pre-metastatic niche is a recently suggested concept, and according to the concept, prior to colonization, the primary tumor induces the remodelling of an organ microenvironment by circulating tumor cells (CTCs). Then, a metastatic niche is produced to support disseminated tumor cells (DTCs) to localize them.[1718] A metastatic niche is a microenvironment that supports and facilitates the invasion and growth of metastasis.[19] Finally, there is a new theory that explains the relationship between the primary and metastatic sites as a bidirectional pathway, rather than unidirectional. According to this theory, the surviving cancer cells in the secondary tumor site have the ability to return to the primary site to accelerate the primary tumor progression.[2021]

RESULTS

Of the 107 case reports of distant metastasis, 67 were in men and 36 in women. The male and female patients' age ranged from 20–92 and 6–79 years, respectively. Distant soft tissue metastases most commonly occurred in the lung with 23 cases, followed by the heart with 10 cases. Metastasis to different bones occurred in 23 cases, with a higher incidence to vertebral bones in 11 cases. In 8 cases, the primary and secondary tumors were discovered at the same time. In 16 cases, the distant metastasis occurred bilaterally, and in 2 cases there were multiple metastases. In 13 cases, the distant metastasis occurred in the contralateral side. In 6 cases, the distant metastasis was the first sign of the presence of a malignancy. In 47 cases, the distant metastasis occurred in more than one site, more commonly in the lung with 22 cases. The most common histologic type was SCC with 55 cases for soft tissue metastases, and ameloblastoma with 23 cases for jaw bone metastases. In addition, there were 18 cases of distant metastasis from the oral cavity minor salivary gland tumors. The details are summarized in Tables 1–3 to aid comparison.
Table 1

Demographic characteristics of distant metastasis from the oral cancer among 67 males

Table 3

Demographic characteristics of distant metastasis from the oral cancer among patients with unknown gender

Demographic characteristics of distant metastasis from the oral cancer among 67 males Demographic characteristics of distant metastasis from the oral cancer among 36 females Demographic characteristics of distant metastasis from the oral cancer among patients with unknown gender

DISCUSSION

There is a high risk of developing a second primary tumor in oral cancer patients.[111] Distant metastasis is another problem with oral cancer which is not so common and correlates with advanced stages of oral cancer.[112] Although the tongue is considered to be the most common site for cancer development, the present review indicated that the gingiva was the most frequent primary site for distant metastasis. A previous study showed that the rate of distant metastasis from the tongue was 4.1%, and was lower than that from upper gingiva carcinomas (6.6%).[113] The lip cancer comprises 30% of the oral cancer and 2.06% of all cancer cases.[114115] The lip carcinoma shows regional lymph node metastasis in 3–29% of cases. In the present review, only 1 case of lip carcinoma metastasis to the lung has been found. Although amelolastoma is histologically a benign and slow growing tumor mostly in the mandible, it can metastasize to the cervical lymph nodes and distant sites.[116] In the present review, 22 cases (20.5%) of distant metastasis from ameloblastoma have been reported. In 15 cases (68%), the distant metastasis was developed in the lungs. In addition, there was a case of mandibular ameloblastoma, metastasiazing to the eye. Metastatic head and neck tumor to the brain is the rare.[69] A previous study has shown that metastasis to the brain occurred in 6% of head and neck cancer patients.[117] In the current review, metastasis to the brain and skull was detected in 10 (9.3%) cases. In conclusion, distant metastasis from the oral cavity is not so common an event, however, because it mostly occurs in the advanced stages of a malignancy, careful examination of the patient during primary cancer treatment has a significant impact on a patient's life.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
Table 2

Demographic characteristics of distant metastasis from the oral cancer among 36 females

  114 in total

Review 1.  Isolated submandibular gland metastasis from oral cavity squamous cell carcinoma.

Authors:  A M Vaidya; A M Vaidya; G J Petruzzelli; K D McClatchey
Journal:  Am J Otolaryngol       Date:  1999 May-Jun       Impact factor: 1.808

2.  Cutaneous metastasis of squamous cell carcinoma of oral mucosa with a purpura-like appearance with tumor thrombosis in lymphatic vessels.

Authors:  Tessin Watanabe; Yuichi Yoshida; Osamu Yamamoto
Journal:  Dermatol Surg       Date:  2010-07-15       Impact factor: 3.398

3.  Mandibular central mucoepidermoid carcinoma with distant metastasis.

Authors:  G A Chiu; R T Woodwards; B Benatar; R Hall
Journal:  Int J Oral Maxillofac Surg       Date:  2011-11-06       Impact factor: 2.789

4.  Mandibular ameloblastoma with intracranial extension and distant metastasis.

Authors:  K Oka; M Fukui; M Yamashita; I Takeshita; K Fujii; K Kitamura; S Nakamura; H Tashiro; S Masuda
Journal:  Clin Neurol Neurosurg       Date:  1986       Impact factor: 1.876

5.  Metastatic patterns in squamous cell cancer of the head and neck.

Authors:  C Kotwall; K Sako; M S Razack; U Rao; V Bakamjian; D P Shedd
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

6.  Malignant ameloblastoma metastasis to the neck--radiological and pathohistological dilemma.

Authors:  Mileta Golubović; Milan Petrović; Drago B Jelovac; Dragoslav U Nenezić; Marija Antunović
Journal:  Vojnosanit Pregl       Date:  2012-05       Impact factor: 0.168

7.  Distant skin metastases in a long-term survivor of malignant ameloblastoma.

Authors:  R M White; J W Patterson
Journal:  J Cutan Pathol       Date:  1986-10       Impact factor: 1.587

8.  Malignant ameloblastoma metastasis to the lung: a case report.

Authors:  Giselle Segnini Senra; Andresa Costa Pereira; Lucio Murilo dos Santos; Yasmin Rodarte Carvalho; Adriana Aigotti Haberbeck Brandão
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-02

Review 9.  Bilateral adrenal metastases and metastatic subcutaneous deposit in the chest wall from osteosarcoma of the mandible: utility of 18F-FDG-PET.

Authors:  Sandip Basu; Tanuja Shet; Sushama Awasare
Journal:  Hell J Nucl Med       Date:  2009 Jan-Apr       Impact factor: 1.102

10.  Cardiac metastasis after squamous cell carcinoma of the base of tongue.

Authors:  Stéphane Hans; Dorian Chauvet; Babak Sadoughi; Daniel F Brasnu
Journal:  Am J Otolaryngol       Date:  2008-10-01       Impact factor: 1.808

View more
  22 in total

1.  Differences between epithelial and mesenchymal human tongue cancer cell lines in experimental metastasis.

Authors:  Wei-Xin Cai; Ru Qing Yu; Li Ma; Hong Zhang Huang; Li Wu Zheng; Roger Zwahlen
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

2.  Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.

Authors:  Yuanyuan Long; Chenxing Li; Baoyu Zhu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  The FnBPA from methicillin-resistant Staphylococcus aureus promoted development of oral squamous cell carcinoma.

Authors:  Li-Xin Kong; Zheng Wang; Yu-Ke Shou; Xue-Dong Zhou; Ya-Wen Zong; Ting Tong; Min Liao; Qi Han; Yan Li; Lei Cheng; Biao Ren
Journal:  J Oral Microbiol       Date:  2022-07-15       Impact factor: 5.833

4.  A Rare Case of Colonic Metastases From Tonsillar Carcinoma: Case Report and Review of Literature.

Authors:  Hassan Tariq; Muhammad Umar Kamal; Shehriyar Mehershahi; Muhammad Saad; Sara Azam; Kishore Kumar; Masooma Niazi; Jasbir Makker; Myrta Daniel
Journal:  World J Oncol       Date:  2018-03-08

5.  Norcantharidin combined with 2-deoxy-d-glucose suppresses the hepatocellular carcinoma cells proliferation and migration.

Authors:  Ragini Singh; Shuang Cheng; Jun Li; Santosh Kumar; Qinghua Zeng; Qingmei Zeng
Journal:  3 Biotech       Date:  2021-02-25       Impact factor: 2.406

Review 6.  Metastasis to the Jawbones: A review of 453 cases.

Authors:  Soussan Irani
Journal:  J Int Soc Prev Community Dent       Date:  2017-03-29

7.  Metabolically Active Subacute Infarct Masquerading as Metastasis: A Finding not to be overlooked in Asymptomatic Oncology Patients.

Authors:  Sumati Sundaraiya; Adhithyan Rajendran; Abubacker Sulaiman; Sivakumar Pradeep; Sivakumar Vidhyadharan; Naveen Hedne
Journal:  Indian J Nucl Med       Date:  2021-03-04

8.  Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population.

Authors:  Hui-Ching Wang; Meng-Chun Chou; Chun-Chieh Wu; Leong-Perng Chan; Sin-Hua Moi; Mei-Ren Pan; Ta-Chih Liu; Cheng-Hong Yang
Journal:  Diagnostics (Basel)       Date:  2021-05-21

9.  Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma.

Authors:  Yajun Shen; Haoyue Xu; Lingyu Li; Yunping Lu; Min Zhang; Xin Huang; Xiaofei Tang
Journal:  Cancer Manag Res       Date:  2021-07-15       Impact factor: 3.989

Review 10.  Resveratrol effects in oral cancer cells: a comprehensive review.

Authors:  Tamires Cunha Almeida; Glenda Nicioli da Silva; Daniel Vitor de Souza; Andrea Cristina de Moraes Malinverni; Odair Aguiar; Debora Estadella; Daniel Araki Ribeiro
Journal:  Med Oncol       Date:  2021-07-17       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.